Eichau, SLópez Ruiz, RCastón Osorio, J JRamírez, EDomínguez-Mayoral, AIzquierdo, G2023-01-252023-01-252018-06-13http://hdl.handle.net/10668/12599enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/AlemtuzumabCytomegalovirusCytomegalovirus InfectionsHumansMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingPrimary cytomegalovirus infection in a patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab.Primoinfección por citomegalovirus en un paciente con esclerosis múltiple recurrente-remitente tratado con alemtuzumab.research article29907474open access10.1016/j.nrl.2018.03.0152173-5808https://doi.org/10.1016/j.nrl.2018.03.015